{"disease":{"id":"borderline-pancreatic-inoperable-cancer","name":"borderline pancreatic inoperable cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03600623","title":"Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}